124 related articles for article (PubMed ID: 27599506)
1. Downregulation of expression of mater genes SOX9, FOXA2, and GATA4 in pancreatic cancer cells stimulated with TGFβ1 epithelial-mesenchymal transition.
Kondratyeva LG; Sveshnikova AA; Grankina EV; Chernov IP; Kopantseva MR; Kopantzev EP; Sverdlov ED
Dokl Biochem Biophys; 2016 Jul; 469(1):257-9. PubMed ID: 27599506
[TBL] [Abstract][Full Text] [Related]
2.
Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
[TBL] [Abstract][Full Text] [Related]
3. The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.
Arfmann-Knübel S; Struck B; Genrich G; Helm O; Sipos B; Sebens S; Schäfer H
PLoS One; 2015; 10(7):e0132978. PubMed ID: 26226105
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells.
Kojima T; Takasawa A; Kyuno D; Ito T; Yamaguchi H; Hirata K; Tsujiwaki M; Murata M; Tanaka S; Sawada N
Exp Cell Res; 2011 Oct; 317(16):2288-98. PubMed ID: 21763689
[TBL] [Abstract][Full Text] [Related]
5. Negative feedback by SNAI2 regulates TGFβ1-induced amelotin gene transcription in epithelial-mesenchymal transition.
Nakayama Y; Tsuruya Y; Noda K; Yamazaki-Takai M; Iwai Y; Ganss B; Ogata Y
J Cell Physiol; 2019 Jul; 234(7):11474-11489. PubMed ID: 30488439
[TBL] [Abstract][Full Text] [Related]
6. 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro.
Yalcin A; Solakoglu TH; Ozcan SC; Guzel S; Peker S; Celikler S; Balaban BD; Sevinc E; Gurpinar Y; Chesney JA
Biochem Biophys Res Commun; 2017 Mar; 484(3):687-693. PubMed ID: 28161638
[TBL] [Abstract][Full Text] [Related]
7. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
8. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
9. SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.
Nishioka R; Itoh S; Gui T; Gai Z; Oikawa K; Kawai M; Tani M; Yamaue H; Muragaki Y
Exp Mol Pathol; 2010 Oct; 89(2):149-57. PubMed ID: 20576520
[TBL] [Abstract][Full Text] [Related]
10. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
Song Y; Washington MK; Crawford HC
Cancer Res; 2010 Mar; 70(5):2115-25. PubMed ID: 20160041
[TBL] [Abstract][Full Text] [Related]
11. Gli1 promotes transforming growth factor-beta1- and epidermal growth factor-induced epithelial to mesenchymal transition in pancreatic cancer cells.
Liu Q; Sheng W; Dong M; Dong X; Dong Q; Li F
Surgery; 2015 Jul; 158(1):211-24. PubMed ID: 25979438
[TBL] [Abstract][Full Text] [Related]
12. Snail-induced epithelial-mesenchymal transition in gastric carcinoma cells and generation of cancer stem cell characteristics.
Yang YJ; Li ZB; Zhang GR; Wu LJ; Yu JY; Hu LJ; Zhou YL; Wang HD; Liang D
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706642
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of dual-specificity phosphatase-26 is required for transforming growth factor β1(TGFβ1)-induced Epithelial-mesenchymal transition in A549 and PANC1 cells.
Guler S; Zik B; Yalcin A
Mol Biol Rep; 2022 Nov; 49(11):10195-10204. PubMed ID: 36053282
[TBL] [Abstract][Full Text] [Related]
14. Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells.
Rahn S; Zimmermann V; Viol F; Knaack H; Stemmer K; Peters L; Lenk L; Ungefroren H; Saur D; Schäfer H; Helm O; Sebens S
Cancer Lett; 2018 Feb; 415():129-150. PubMed ID: 29222037
[TBL] [Abstract][Full Text] [Related]
15. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
16. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
Odero-Marah VA; Wang R; Chu G; Zayzafoon M; Xu J; Shi C; Marshall FF; Zhau HE; Chung LW
Cell Res; 2008 Aug; 18(8):858-70. PubMed ID: 18645583
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
18. Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion.
Kabashima A; Higuchi H; Takaishi H; Matsuzaki Y; Suzuki S; Izumiya M; Iizuka H; Sakai G; Hozawa S; Azuma T; Hibi T
Int J Cancer; 2009 Jun; 124(12):2771-9. PubMed ID: 19296540
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transforming growth factor-β release from tumor cells reduces their motility associated with epithelial-mesenchymal transition.
Ohshio Y; Teramoto K; Hashimoto M; Kitamura S; Hanaoka J; Kontani K
Oncol Rep; 2013 Aug; 30(2):1000-6. PubMed ID: 23715805
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells.
Taki M; Verschueren K; Yokoyama K; Nagayama M; Kamata N
Int J Oncol; 2006 Feb; 28(2):487-96. PubMed ID: 16391805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
